# FDA Inspection 1223324 - WES Pharma Inc. - November 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/wes-pharma-inc/37ef8a8b-4e2f-433a-b55a-1a0aa0bf154b
Source feed: FDA_Inspections

> FDA Inspection 1223324 for WES Pharma Inc. on November 21, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1223324
- Company Name: WES Pharma Inc.
- Inspection Date: 2023-11-21
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1290200 - 2025-11-20](https://www.keypedia.com/records/fda_inspections/wes-pharma-inc/86fcfabf-984e-4912-bcd9-e4ce9321452c)
- [FDA Inspection 1162565 - 2022-02-18](https://www.keypedia.com/records/fda_inspections/wes-pharma-inc/2264969c-807b-43bf-9ace-79ba39b3886e)
- [FDA Inspection 1141774 - 2021-04-28](https://www.keypedia.com/records/fda_inspections/wes-pharma-inc/0223ccd6-bcea-4792-9ded-853c2c0bd109)
- [FDA Inspection 1114327 - 2019-12-20](https://www.keypedia.com/records/fda_inspections/wes-pharma-inc/a3fdb5c9-d88d-4b5a-8b64-ab1c3cf28592)
- [FDA Inspection 1088267 - 2019-04-19](https://www.keypedia.com/records/fda_inspections/wes-pharma-inc/77a565d3-899b-466f-9b49-b46e7e538afb)

Company: https://www.keypedia.com/companies/wes-pharma-inc/26195242-bcfc-4382-817b-4d9d153b962d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c